Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)
Active, not recruitingOBSERVATIONAL
Enrollment
219
Participants
Timeline
Start Date
May 6, 2022
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2030
Conditions
Myeloproliferative DiseaseCOVID - 19
Trial Locations (1)
27100
Fondazione IRCCS Policlinico San Matteo, Pavia
All Listed Sponsors
lead
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
NCT07204366 - Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study) | Biotech Hunter | Biotech Hunter